Low Allergenic Potential With Fondaparinux: Results of a Prospective Investigation-Reference-Cited by-同舟云学术

Low Allergenic Potential With Fondaparinux: Results of a Prospective Investigation

Published:2010-10 Issue:10 Volume:85 Page:913-919
ISSN:0025-6196
Container-title:Mayo Clinic Proceedings
language:en
Short-container-title:Mayo Clinic Proceedings

Author:

Schindewolf Marc,Scheuermann Julia,Kroll Hartmut,Garbaraviciene Jurate,Hecking Carola,Marzi Ingo,Wolter Manfred,Kaufmann Roland,Boehncke Wolf-Henning,Lindhoff-Last Edelgard,Ludwig Ralf J.

Publisher

Elsevier BV

Subject

General Medicine

Reference36 articles.

1. Chemical synthesis of glycosaminoglycans: new approaches to antithrombotic drugs;Petitou;Nature,1991

2. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition);Kearon;Chest,2008

3. Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition);Harrington;Chest,2008

4. Management of cutaneous type IV hypersensitivity reactions induced by heparin;Ludwig;Thromb Haemost,2006

5. Heparin allergy: delayed-type non-IgE-mediated allergic hypersensitivity to subcutaneous heparin injection;Trautmann;Immunol Allergy Clin North Am,2009

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Shake it off: A curious case of rigors;Journal of the National Medical Association;2023-06

2. Delayed-Type Heparin Allergy: Intravenous Tolerance Despite Inflammatory Skin Reaction After Subcutaneous Injection;The Journal of Allergy and Clinical Immunology: In Practice;2022-11

3. Fondaparinux Pre-, Peri-, and/or Postpartum for the Prophylaxis/Treatment of Venous Thromboembolism (FondaPPP);Clinical and Applied Thrombosis/Hemostasis;2021-01-01

4. Sustained drug-related reaction with eosinophilia and systemic symptoms (DRESS) triggered by low molecular weight heparins in COVID-19: management and precision diagnosis;Advances in Dermatology and Allergology;2021

5. Treating COVID-19: Review of Drug Hypersensitivity Reactions;Journal of Investigational Allergology and Clinical Immunology;2020-12-10